Not adopted
This amendment was never taken up, and the bill finished without it. It was never voted on.
Its path through Congress
- Introduced
- Pending Consideration
- Failed
What this amendment would do
This amendment would change the rules regarding how orphan drugs, which are drugs used to treat rare diseases or conditions, are treated under the Drug Price Negotiation Program.
The amendment would change the language to allow a drug to be described as treating one or more rare diseases or conditions instead of only one.
It also instructs the Secretary to exclude certain time periods when calculating how much time has passed since a drug or biological product was approved.
This calculation would not include any time during which the drug or product was considered a drug described in the specific section of the law mentioned in the text.
- 6/29/2025
- Senate amendment submitted
This bill has no cosponsors